section 8
on 19 Mar 2005
Last Applicant/ Owned by
Frankfurt am Main
DE
Serial Number
75069401 filed on 08th Mar 1996
Registration Number
2166246 registered on 16th Jun 1998
Correspondent Address
Margaret H. Bitler
Aventis Pharmaceuticals Inc.
(Mail Stop: BW-D-335)
Route #202-206 N P.O. Box 6800
Bridgewater NJ 08807-0800
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
In the statement, Column 2, before line 4, "TUMOR THERAPEUTICS" should be inserted. psychotropics/drugs for treatment of central nervous system, cardiovascular agents, vasotherapeutics, antiinfectives/antibiotics/chemotherapeutics/antiviral agents, hormones, metabolic agents/antidiabetic drugs, agents for digestive (gastrointestinal) disorders, antiallergic drugs, analgesics/spasmolytic drugs/narRead More
psychotropics/drugs for treatment of central nervous system, cardiovascular agents, vasotherapeutics, antiinfectives/antibiotics/chemotherapeutics/antiviral agents, hormones, metabolic agents/antidiabetic drugs, agents for digestive (gastrointestinal) disorders, antiallergic drugs, analgesics/spasmolytic drugs/narcotics/anesthetics/antiphlogistics, * tumor therapeutics * dermatological preparations, antiemetics, osteoporose drugs
31st Jan 1996
31st Jan 1996
No 75069401
No Service/Collective Mark
No HOE.96.3407
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Mar 2005 | CANCELLED SEC. 8 (6-YR) |
| 19th Sep 2002 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 11th Dec 1998 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 17th Jul 1998 | SEC 7 REQUEST FILED |
| 16th Jun 1998 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Apr 1998 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 22nd Apr 1998 | ASSIGNED TO EXAMINER |
| 20th Apr 1998 | STATEMENT OF USE PROCESSING COMPLETE |
| 13th Feb 1998 | EXTENSION 1 GRANTED |
| 15th Jan 1998 | USE AMENDMENT FILED |
